Penn Capital Management Company LLC acquired a new stake in Aehr Test Systems (NASDAQ:AEHR – Free Report) in the 2nd quarter, according to the company in its most recent filing with the SEC. The fund acquired 150,547 shares of the semiconductor company’s stock, valued at approximately $14,476,000.
Other institutional investors also recently modified their holdings of the company. Advocate Investing Services LLC acquired a new stake in Aehr Test Systems in the second quarter worth $26,000. Compagnie Lombard Odier SCmA bought a new position in shares of Aehr Test Systems during the 2nd quarter worth about $34,000. Millennium Management LLC boosted its position in shares of Aehr Test Systems by 0.8% during the 4th quarter. Millennium Management LLC now owns 59,219 shares of the semiconductor company’s stock worth $1,196,000 after purchasing an additional 492 shares in the last quarter. KBC Group NV acquired a new stake in shares of Aehr Test Systems in the 1st quarter valued at about $30,000. Finally, CoreCap Advisors LLC increased its position in Aehr Test Systems by 241.8% in the 2nd quarter. CoreCap Advisors LLC now owns 1,251 shares of the semiconductor company’s stock valued at $120,000 after buying an additional 885 shares in the last quarter. Institutional investors and hedge funds own 69.69% of the company’s stock.
Insider Transactions at Aehr Test Systems
In related news, Director Rhea J. Posedel sold 5,973 shares of the company’s stock in a transaction on Friday, August 14th. The stock was sold at an average price of $140.00, for a total transaction of $836,220.00. Following the completion of the sale, the director owned 381,989 shares in the company, valued at approximately $53,478,460. This represents a 1.54% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, Director Laura Oliphant sold 1,717 shares of the stock in a transaction on Wednesday, August 12th. The shares were sold at an average price of $133.00, for a total value of $228,361.00. Following the completion of the sale, the director directly owned 16,100 shares of the company’s stock, valued at $2,141,300. The trade was a 9.64% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last quarter, insiders sold 109,475 shares of company stock valued at $13,827,160. Corporate insiders own 6.80% of the company’s stock.
Wall Street Analyst Weigh In
Check Out Our Latest Stock Analysis on Aehr Test Systems
Trending Headlines about Aehr Test Systems
Here are the key news stories impacting Aehr Test Systems this week:
- Positive Sentiment: Jefferies initiated coverage with a bullish view, helping drive renewed investor interest. The analyst reportedly described the price target as conservative and identified additional potential catalysts that were not included in the model. Jefferies Initiates Coverage on Aehr Test Systems
- Positive Sentiment: Aehr received a $22 million follow-on order from its lead customer for wafer-level burn-in systems used with advanced AI training and inference processors. The repeat business supports demand for the company’s FOX systems and strengthens its position in AI and high-performance computing. Aehr Receives $22 Million Follow-on Order
- Positive Sentiment: Recent company updates pointed to record quarterly bookings of $60.7 million, a backlog of approximately $100.6 million and fiscal 2027 revenue guidance of $130 million to $150 million. These figures provide revenue visibility and support the investment case tied to rising AI-chip testing demand. Aehr AI Order and WLBI Opportunity
- Neutral Sentiment: CEO Gayn Erickson and CFO Chris Siu will meet investors at the Needham Virtual Semiconductor and SemiCap 1×1 Conference on August 19. The event could provide further commentary on backlog conversion and fiscal 2027 execution, but no new financial information was announced. Aehr to Participate in Needham Conference
- Negative Sentiment: Several insiders sold shares after AEHR’s sharp rally. The transactions included the CEO’s sale of 40,000 shares for about $5.2 million, the COO’s sale of 15,000 shares for roughly $2.0 million, and additional director and executive sales. Although insiders retained sizable positions—and the CEO sale came from a trust—such activity may signal profit-taking and add selling pressure. Aehr CEO Share Sale
- Negative Sentiment: One analyst began coverage on a bearish note, highlighting the risk that expectations have become difficult to meet after the stock’s extraordinary advance. AEHR’s elevated valuation and dependence on continued AI order growth leave it vulnerable if bookings, backlog conversion or execution disappoints. Bearish Analyst Initiation
Aehr Test Systems Stock Performance
AEHR stock opened at $134.06 on Friday. The company has a market capitalization of $4.37 billion, a P/E ratio of -558.56 and a beta of 3.10. Aehr Test Systems has a 52-week low of $16.38 and a 52-week high of $147.40. The business has a 50-day simple moving average of $92.83 and a two-hundred day simple moving average of $71.45.
About Aehr Test Systems
Aehr Test Systems develops, manufactures and sells semiconductor test and burn-in equipment used by device manufacturers to ensure quality and reliability of integrated circuits. Its products are designed for wafer-level reliability assessment, functional test and stress screening of memory devices, system-on-chips, optical components and power semiconductors. By focusing on wafer-level burn-in and testing processes, the company helps reduce cost and improve yield for high-volume semiconductor production.
The company’s product portfolio includes FOX series wafer probe test and burn-in systems as well as ABTS burn-in ovens.
Read More
- Five stocks we like better than Aehr Test Systems
- Sony and TSMC’s $4.7 Billion Venture Is About More Than Camera Sensors
- Quantum Leaps: Debt-Free as AI Storage Demand Accelerates
- NVIDIA’s $500 Billion GPU Financing Deal Fuels Path Toward $270
- Sandisk’s Margins Look Like Software. Can They Last?
Want to see what other hedge funds are holding AEHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aehr Test Systems (NASDAQ:AEHR – Free Report).
Receive News & Ratings for Aehr Test Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aehr Test Systems and related companies with MarketBeat.com's FREE daily email newsletter.
